MNKD - MannKind Corporation

MannKind Corporation

30930 Russell Ranch Road
Suite 300
Westlake Village, CA 91362
United States
818-661-5000
http://www.mannkindcorp.com

Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 225

Key Executives

Name	Title	Pay	Exercised	Year Born
Dr. Michael E. Castagna	CEO & Director	675.7k	N/A	1977
Mr. Steven B. Binder	Chief Financial Officer	520.45k	N/A	1963
Dr. David B. Thomson	Exec. VP, Gen. Counsel & Sec.	581.28k	N/A	1967
Mr. James Patrick McCauley Jr., J.D., M.B.A.	Chief Commercial Officer	731.64k	N/A	1966
Dr. David M. Kendall M.D.	Chief Medical Officer	685.23k	N/A	1962

Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for diabetes and pulmonary arterial hypertension patients. It offers Afrezza, a dry powder formulation of human insulin that controls high blood sugar in adults with type 1 and type 2 diabetes in the United States. The company has a licensing and collaboration agreement with United Therapeutics Corporation for the development and commercialization of a dry powder formulation of treprostinil used for the treatment of pulmonary arterial hypertension. MannKind Corporation was founded in 1991 and is headquartered in Westlake Village, California.

Corporate Governance

MannKind Corporation’s ISS Governance QualityScore as of July 29, 2019 is 7. The pillar scores are Audit: 5; Board: 6; Shareholder Rights: 4; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.